Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors is a research paper published in JAMA Network Open (2022). On theSindex it has a DataRank of 0.434. It has been cited 17 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.434
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCATS NIH HHS
Grant: UL1 TR001863
NIA NIH HHS
Grant: R01 AG065805
NCATS NIH HHS
Grant: UL1 TR002538
NCATS NIH HHS
Grant: UL1 TR003142
NIA NIH HHS
Grant: P30 AG072947
National Institutes of Health
Grant: 3UL1TR000075-05S1
Clinical and Translational Science Institute at Children's National
National Institutes of Health
Grant: 5K76AG059929-03
Antihypertensives and the Aging Brain
National Institutes of Health
Grant: 5R01HL157108-03
Cardiovascular Risk, Vascular and Kidney Damage in COVID-19 Survivors
National Institutes of Health
Grant: 5U24DK060990-22
Continuation of the Coordinating Center for the Chronic Renal Insufficiency Cohort (CRIC) Study
National Institutes of Health
Grant: 1K23HL133843-01
Management of hypertension in obesity: Antihypertensive class effects, blood pressure control, and renal and cardiac outcomes
National Institutes of Health
Grant: 3UL1RR024134-06S2
Institutional Clinical and Translational Science Award
National Institutes of Health
Grant: 4P30GM103337-05
Translational Research in Hypertension and Renal Biology
National Institutes of Health
Grant: 3UL1TR000433-08S1
Michigan Institute for Clinical and Health Research (MCHR)
National Institutes of Health
Grant: 3UL1TR000093-05S1
Stanford Center for Clinical and Translational Education and Research (SCCTER)UL1
National Institutes of Health
Grant: 3UL1RR025755-04S1
The Ohio State University Center for Clinical and Translational Science (UL1)
National Institutes of Health
Grant: 3UL1TR000445-08S1
The Vanderbilt Institute for Clinical and Translational Research (VICTR)
National Institutes of Health
Grant: 2UL1TR000439-06
Clinical and Translational Science Collaborative of Cleveland
National Institutes of Health
Grant: 5UL1TR000050-05
Center for Clinical and Translational Science
National Institutes of Health
Grant: 3R01DK123104-03S1
Home Blood Pressure in Hemodialysis (HOME-BP)
National Institutes of Health
Grant: 3U01TR003734-01S1
Efficacy of Fenofibrate for COVID-19: A phase II randomized controlled trial
National Institutes of Health
Grant: 8UL1TR000005-07
University of Pittsburgh Clinical and Translational Science Institute
National Institutes of Health
Grant: 5U01HL160277-03
HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets - Clinical Centers
National Institutes of Health
Grant: 3UL1TR000064-05S2
UF Clinical and Translational Science Award
National Institutes of Health
Grant: 8UL1TR000003-07
Institutional Clinical and Translational Science Award
National Institutes of Health
Grant: 3UL1RR025752-02S4
TUFTS CLINICAL AND TRANSLATION SCIENCE INSTITUTE (UL1): BPCA
National Institutes of Health
Grant: 3UL1TR001064-02S1
Tufts Clinical and Translational Research Institute
National Institutes of Health
Grant: 5R01HL153646-04
Blockade of calcium channels and beta adrenergic receptors for physiologic abnormalities in heart failure with preserved ejection fraction (BLOCK HFpEF)
National Institutes of Health
Grant: 8UL1TR000073-05
Tufts Clinical and Translation Science Institute (UL1)
National Institutes of Health
Grant: 6UL1TR000445-11
The Vanderbilt Institute for Clinical and Translational Research (VICTR)
National Institutes of Health
Grant: 3UL1TR000105-05S1
University of Utah Center for Clinical and Translational Science-UL1
National Institutes of Health
Grant: 1UL1RR025771-01
BOSTON UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD (CTSA) PROGRAM UL1
FWCI
1.83
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals